Nektar Therapeutics (NKTR) Insider Trading

Total insider buys:
  • $1,135,850.00
Total insider sells:
  • $232,543,735.70
Most recent insider trade:
  • Nov. 19, 2024
Most active insider trader:
  • Howard W Robin
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 19, 2024Insider7,785$1.01Sell$7,862.85
Nov. 19, 2024CEO16,278$1.01Sell$16,440.78
Aug. 19, 2024Insider6,866$1.28Sell$8,788.48
Aug. 19, 2024CEO14,881$1.28Sell$19,047.68
June 14, 2024Director19,500$1.20Sell$23,400.00
May 17, 2024Insider7,355$1.75Sell$12,871.25
May 17, 2024CEO16,650$1.75Sell$29,137.50
May 10, 2024Major Shareholder56,000$1.78Sell$99,680.00
Feb. 20, 2024Insider9,014$0.68Sell$6,129.52
Feb. 20, 2024CEO20,033$0.68Sell$13,622.44
Nov. 17, 2023CEO19,877$0.49Sell$9,739.73
Nov. 17, 2023Insider9,646$0.49Sell$4,726.54
Sept. 18, 2023Director4,359$0.69Sell$3,007.71
Aug. 16, 2023Insider9,703$0.78Sell$7,568.34
Aug. 16, 2023CEO19,998$0.78Sell$15,598.44
June 14, 2023Director30,000$0.57Sell$17,100.00
May 16, 2023CEO20,361$0.72Sell$14,659.92
May 16, 2023Insider9,791$0.72Sell$7,049.52
Feb. 16, 2023Insider10,484$3.00Sell$31,452.00
Feb. 16, 2023CFO10,267$3.00Sell$30,801.00
Feb. 16, 2023CEO19,635$3.00Sell$58,905.00
Nov. 16, 2022Insider13,460$3.57Sell$48,052.20
Nov. 16, 2022CEO38,014$3.57Sell$135,709.98
Nov. 16, 2022CFO11,095$3.57Sell$39,609.15
Sept. 23, 2022Director4,198$3.16Sell$13,265.68
Sept. 13, 2022Director21,267$3.61Sell$76,773.87
Aug. 18, 2022Insider73,716$4.65Sell$342,779.40
Aug. 16, 2022CAO2,006$4.76Sell$9,548.56
Aug. 16, 2022CEO13,759$4.76Sell$65,492.84
Aug. 16, 2022Insider10,560$4.76Sell$50,265.60
Aug. 16, 2022SVP3,189$4.76Sell$15,179.64
May 16, 2022CFO17,448$3.95Sell$68,919.60
May 16, 2022CAO5,841$3.95Sell$23,071.95
May 16, 2022SVP3,136$3.95Sell$12,387.20
May 16, 2022CEO36,529$3.95Sell$144,289.55
May 16, 2022Insider21,673$3.95Sell$85,608.35
Feb. 16, 2022CEO12,480$10.95Sell$136,656.00
Feb. 16, 2022Insider10,912$10.95Sell$119,486.40
Feb. 16, 2022CAO2,363$10.95Sell$25,874.85
Feb. 16, 2022SVP4,852$10.95Sell$53,129.40
Feb. 16, 2022CFO7,579$10.95Sell$82,990.05
Nov. 18, 2021CFO3,000$12.69Sell$38,070.00
Nov. 16, 2021CFO21,149$13.16Sell$278,320.84
Sept. 22, 2021Director3,665$17.78Sell$65,163.70
Sept. 8, 2021Director8,000$16.00Sell$128,000.00
Aug. 16, 2021CFO7,867$13.83Sell$108,800.61
Aug. 16, 2021CEO11,515$13.83Sell$159,252.45
Aug. 16, 2021SVP1,910$13.83Sell$26,415.30
Aug. 16, 2021Insider7,662$13.83Sell$105,965.46
Aug. 16, 2021CAO13,339$13.83Sell$184,478.37
First«1 of 6»Last
  • Insiders are both buying and selling Nektar Therapeutics stock.

  • The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein

  • The most active insider trader at Nektar Therapeutics is Howard W Robin with 49 trades.

  • Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,286,240.28.

  • Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.

  • The most recent insider trade for Nektar Therapeutics was on Nov. 19, 2024.

  • The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.

  • The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.